TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies.
TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies.TVM Capital was founded in 1983 and is based Munich, Bavaria.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 16, 2014
Proteon Therapeutics
|
Series D | $45M | Biotechnology | — |
Jul 25, 2012
Bluebird Bio
|
Series D | $60M | Biotechnology | — |
Aug 12, 2011
Proteon Therapeutics
|
Series C | $15.20M | Biotechnology | Yes |
Apr 20, 2011
Bluebird Bio
|
Series C | $30M | Biotechnology | — |
Mar 12, 2010
Bluebird Bio
|
Series B | $35M | Biotechnology | — |